Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and Adenine

FDA Drug Profile — teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1, TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1, TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood

Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and Adenine is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1, TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1, TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood. Available dosage form: solution.

Drug details

Generic Name
Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and Adenine
Brand Names
teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1, TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1, TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood
Application Number
BN820528
Sponsor
Terumo Corporation
NDC Codes
3
Dosage Forms
SOLUTION
Routes
INTRAVENOUS
Active Ingredients
ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, ADENINE

Indications and Usage

1. INDICATIONS AND USAGE 1.1. Read these instructions carefully before use. 1.2. Rx ONLY. 1.3. Intended for the collection, processing and preservation of Whole Blood and blood components. Not intended for direct intravenous infusion. 1.4. For the collection of 450 mL ±10% or 500 mL ±10% Whole Blood. 1.5. Integral Diversion Blood Sampling Arm is intended to divert and obtain donor samples for laboratory testing prior to collection of the Whole Blood unit. 1.6. For further processing, use standard component processing techniques.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.